Erfan Taherifard
Postdoctoral AssociateAbout
Research
Publications
2024
Biomarkers for Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma: A Comprehensive Review.
Taherifard E, Tran K, Saeed A, Yasin JA, Saeed A. Biomarkers for Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma: A Comprehensive Review. Diagnostics (Basel) 2024, 14 PMID: 39335733, DOI: 10.3390/diagnostics14182054.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsThe medication usage pattern and prevalence of polypharmacy among patients with sickle cell disease: a population-based study in southern Iran.
Amini A, Taherifard E, Akbari M, Taherifard E, Dehdari Ebrahimi N, Rajabi MR, Zamani F, Rekabpour SJ, Jafaraghaie R, Hassanzadeh J, Molavi Vardanjani H. The medication usage pattern and prevalence of polypharmacy among patients with sickle cell disease: a population-based study in southern Iran. Expert Rev Hematol 2024, 17: 643-650. PMID: 39061121, DOI: 10.1080/17474086.2024.2385482.Peer-Reviewed Original ResearchNeoadjuvant PD-1/PD-L1 inhibitors plus chemotherapy in resectable gastric and gastroesophageal junction cancer.
Taherifard E, Saeed A. Neoadjuvant PD-1/PD-L1 inhibitors plus chemotherapy in resectable gastric and gastroesophageal junction cancer. Transl Gastroenterol Hepatol 2024, 9: 59. PMID: 39503035, DOI: 10.21037/tgh-24-44.Commentaries, Editorials and LettersEpidemiological and clinical characteristics of long COVID-19 among Iranians: A community-based study in southern Iran.
Askarian M, Taherifard E, Jazzabi F, Shayan Z, Assadian O, Groot G, Hatam N, Askarian A, Faghihi SM, Taherifard E. Epidemiological and clinical characteristics of long COVID-19 among Iranians: A community-based study in southern Iran. BMC Public Health 2024, 24: 2007. PMID: 39061051, DOI: 10.1186/s12889-024-19543-1.Peer-Reviewed Original ResearchPredicting liver function after hemihepatectomy in patients with hepatocellular carcinoma using different modalities.
Taherifard E, Saeed A. Predicting liver function after hemihepatectomy in patients with hepatocellular carcinoma using different modalities. World J Clin Oncol 2024, 15: 783-785. PMID: 38946834, DOI: 10.5306/wjco.v15.i6.783.Commentaries, Editorials and LettersElectrocardiographic findings in patients with sickle cell disease: A protocol for systematic review and meta-analysis.
Sadeghi A, Taherifard E, Movahed H, Ahmadkhani A, Dehdari Ebrahimi N, Taherifard E. Electrocardiographic findings in patients with sickle cell disease: A protocol for systematic review and meta-analysis. Health Sci Rep 2024, 7: e2212. PMID: 38915361, DOI: 10.1002/hsr2.2212.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMASLD-Related HCC: A Comprehensive Review of the Trends, Pathophysiology, Tumor Microenvironment, Surveillance, and Treatment Options.
Shi Y, Taherifard E, Saeed A, Saeed A. MASLD-Related HCC: A Comprehensive Review of the Trends, Pathophysiology, Tumor Microenvironment, Surveillance, and Treatment Options. Curr Issues Mol Biol 2024, 46: 5965-5983. PMID: 38921027, DOI: 10.3390/cimb46060356.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsElectrocardiographic abnormalities in patients with sickle cell disease: A systematic review and meta-analysis.
Taherifard E, Movahed H, Taherifard E, Sadeghi A, Dehdari Ebrahimi N, Ahmadkhani A, Kheshti F, Movahed H. Electrocardiographic abnormalities in patients with sickle cell disease: A systematic review and meta-analysis. Pediatr Blood Cancer 2024, 71: e30916. PMID: 38348531, DOI: 10.1002/pbc.30916.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsPrevalence of metabolically healthy obesity and healthy overweight and the associated factors in southern Iran: A population-based cross-sectional study.
Taherifard E, Taherifard E, Jeddi M, Ahmadkhani A, Kelishadi R, Poustchi H, Gandomkar A, Malekzadeh F, Mohammadi Z, Molavi Vardanjani H. Prevalence of metabolically healthy obesity and healthy overweight and the associated factors in southern Iran: A population-based cross-sectional study. Health Sci Rep 2024, 7: e1909. PMID: 38361808, DOI: 10.1002/hsr2.1909.Peer-Reviewed Original ResearchEfficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis.
Taherifard E, Bakhtiar M, Mahnoor M, Ahmed R, Cavalcante L, Zhang J, Saeed A. Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis. BMC Cancer 2024, 24: 192. PMID: 38347461, DOI: 10.1186/s12885-024-11926-2.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements